BPN 2012 Program Highlights
January 17, 2012
Renowned top level pharma executives will share insight on topics about collaboration strategies for innovation in life science which allows creative concepts to become positive outcomes.
View the full BPN 2012 Program on the BPN website.
  Keynote Address - GlaxoSmithKline Inc.Paul Lucas, President & CEO GlaxoSmithKline Inc. Title: Advancing the Commercialization of Canadian Life Sciences In this presentation Paul Lucas will provide an overview of GSK Canada and highlight two key collaboration strategies (R&D/BD partnerships with GSK & the GSK Canada Life Sciences Innovation Fund) to help advance innovation in the Life Sciences from conceptual to real medicines that positively impact patient outcomes. Learn about this funding model for Canadian biotech companies. |
|||
 |
Keynote Address - AstraZeneca Ms. Elaine Campbell, President and Chief Executive Officer, AstraZeneca Canada Inc. View Speaker BIO |
||
 |
Keynote Address - Pfizer Dr. Uwe Schoenbeck, Chief Scientific Officer, External Research & Development, Pfizer View Program |
||